Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alexander O. König"'
Autor:
Ruben Evertz, Christine Diehl, Katharina Gödde, Miroslava Valentova, Tania Garfias-Veitl, Tobias R. Overbeck, Friederike Braulke, Alessia Lena, Sara Hadzibegovic, Annalen Bleckmann, Ulrich Keller, Ulf Landmesser, Alexander O. König, Gerd Hasenfuss, Andreas Schuster, Markus S. Anker, Stephan von Haehling
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Maintaining cancer patients’ exercise capacity and therefore patients’ ability to live a self-determined life is of huge importance, but little is known about major determinants. We sought to identify determinants of exercise capacity in
Externí odkaz:
https://doaj.org/article/714f73e5313b4f03983b1731284c9e65
Autor:
Ruben Evertz, Katharina Gödde, Christine Diehl, Miroslava Valentova, Tania Garfias‐Veitl, Friederike Braulke, Gerald G. Wulf, Tobias R. Overbeck, Annalen Bleckmann, Alexander O. König, Pia Weinländer, Sophia Potthoff, Sara Hadzibegovic, Alessia Lena, Ulrich Keller, Ulf Landmesser, Andreas Schuster, Markus S. Anker, Gerd Hasenfuß, Stephan vonHaehling
Publikováno v:
ESC Heart Failure, Vol 10, Iss 1, Pp 167-176 (2023)
Abstract Aims Maintaining quality of life (QoL) in patients with cancer has gathered significant interest, but little is known about its major determinants. We sought to identify determinants of QoL in patients undergoing cancer treatment as well as
Externí odkaz:
https://doaj.org/article/586093e844e2498bae29c65f7e2a7ebf
Autor:
Ruben Evertz, Katharina Gödde, Christine Diehl, Miroslava Valentova, Tania Garfias‐Veitl, Friederike Braulke, Gerald G. Wulf, Tobias R. Overbeck, Annalen Bleckmann, Alexander O. König, Pia Weinländer, Sophia Potthoff, Sara Hadzibegovic, Alessia Lena, Ulrich Keller, Ulf Landmesser, Andreas Schuster, Markus S. Anker, Gerd Hasenfuß, Stephan von Haehling
Publikováno v:
ESC heart failureReferences.
AIMS: Maintaining quality of life (QoL) in patients with cancer has gathered significant interest, but little is known about its major determinants. We sought to identify determinants of QoL in patients undergoing cancer treatment as well as in treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3810d8cf04e0895004555efc206a6ce0
https://pubmed.ncbi.nlm.nih.gov/36178215
https://pubmed.ncbi.nlm.nih.gov/36178215
Autor:
Sebastian C. B. Bremer, Gabi Bittner, Omar Elakad, Helen Dinter, Jochen Gaedcke, Alexander O. König, Ahmad Amanzada, Volker Ellenrieder, Alexander Freiherr von Hammerstein-Equord, Philipp Ströbel, Hanibal Bohnenberger
Publikováno v:
Cancers; Volume 14; Issue 12; Pages: 2828
Tumor grading is a robust prognostic predictor in patients with neuroendocrine neoplasms (NEN) and guides therapy, especially in tumors with high proliferation. NEN can be separated into well-differentiated and poorly differentiated types. The more a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36c10d091337c5122ccedc06d7fcfcfa
https://doi.org/10.3390/cancers14122828
https://doi.org/10.3390/cancers14122828